Read + Share
Wang C, Zhao K, Hu S, Dong W, et al. Clinical outcomes of gefitinib and erlotinib in patients with NSCLC harboring
uncommon EGFR mutations: A pooled analysis of 438 patients. Lung Cancer 2022;172:86-93.
PMID: 36027855
|
 |
|
Wang C, Zhao K, Hu S, Dong W, et al. Clinical outcomes of gefitinib and erlotinib in patients with NSCLC harboring
uncommon EGFR mutations: A pooled analysis of 438 patients. Lung Cancer 2022;172:86-93.
PMID: 36027855
|
|
|
|